Anterior Leaflet Clip Device for Prosthetic Mitral Valve

• US 20140296969A1
• Filed: 01/14/2014
• Published: 10/02/2014
• Est. Priority Date: 04/02/2013
• Status: Abandoned Application

• Current Assignee: Tendyne Holdings Inc. (Abbott Laboratories Incorporated)
• Original Assignee: Tendyne Holdings Inc. (Abbott Laboratories Incorporated)
• Inventors: TEGELS, Zachary J., VIDLUND, Robert M., EKVALL, Craig A.
• Application Number:
  US14/154,546
• Publication Number:
  US 20140296969A1
• Time in Patent Office: Days
• US Class Current: 623/2.11
• CPC Class Codes: A61F 2/2412 with soft flexible valve members, e.g. tissue valves shaped like natural valves check valves with flexible valve members in general F16K15/14
• CPC Class Codes: A61F 2/2439 Expansion controlled by filaments
• CPC Class Codes: A61F 2/2487 Devices within the heart chamber, e.g. splints
• CPC Class Codes: A61F 2220/0008 Fixation appliances for connecting prostheses to the body
• CPC Class Codes: A61F 2250/0069 Sealing means

Abstract

This invention relates to a pre-configured compressible transcatheter prosthetic cardiovascular valve having an improved anterior leaflet clip device. The invention also relates to methods for deploying such a valve for treatment of a patient in need thereof.

Claims

1. A pre-configured compressible transcatheter prosthetic cardiovascular valve having an anterior leaflet clip device, which comprises an expandable leaflet assembly comprised of stabilized tissue or synthetic material disposed within an expandable stent having at a distal end a plurality of articulating collar support structures having a tissue covering to form an atrial collar, said expandable stent having a proximal end comprised of an integral tether connection apparatus, said anterior leaflet clip device comprising a folding component that is mounted on the expandable stent, said folding component having a hinge segment and a leaflet capture and attachment segment.

2. The prosthetic heart valve of claim 1, further comprising wherein the anterior leaflet clip device is an integrated component of the expandable stent.

3. The prosthetic heart valve of claim 1, further comprising wherein the anterior leaflet clip device is a separate component that is sutured to the expanded stent before deployment of the valve, the device having a mounting segment connected to the hinge segment which is connected to the leaflet capture and attachment segment.

4. The anterior leaflet clip of claim 1, further comprising a plurality of pre-aligned suture holes in the leaflet capture and attachment segment.

5. The anterior leaflet clip of claim 3, further comprising a plurality of pre-aligned suture holes in the mounting segment and the leaflet capture and attachment segment wherein the suture holes line up in a substantially adjacent manner after the leaflet capture and attachment segment is folded over.

6. The prosthetic heart valve of claim 1, further comprising wherein the expandable stent has a low height to width profile.

7. The prosthetic heart valve of claim 1, further comprising wherein the expandable stent is a half-round D-shape in cross-section.

8. The prosthetic heart valve of claim 1, wherein the expandable stent is made from superelastic metal.

9. The prosthetic heart valve of claim 5, further comprising wherein the superelastic metal is a nickel-titanium alloy.

10. The prosthetic heart valve of claim 5, wherein the stent and cuff are formed from the same piece of superelastic metal.

11. The prosthetic heart valve of claim 1, further comprising wherein the expandable stent and collar are covered with stabilized tissue is derived from adult, 90-day old, or 30-day old, bovine, ovine, equine or porcine pericardium, or from animal small intestine submucosa.

12. The prosthetic heart valve of claim 1, further comprising wherein the expandable stent and collar are covered with synthetic material selected from the group consisting of polyester, polyurethane, polytetrafluoroethylene or another elastomeric material.

13. The prosthetic heart valve of claim 1, wherein the elastomeric material, stabilized tissue or synthetic material is treated with anticoagulant.

14. The prosthetic heart valve of claim 1, wherein the elastomeric material, the stabilized tissue or synthetic material is heparinized.

15. The prosthetic heart valve of claim 1, wherein integral tether connection apparatus has a plurality of tether attachment structures with anchoring tethers attached for anchoring the prosthetic heart valve to tissue.

16. The prosthetic heart valve of claim 15, wherein at least one of the plurality of tethers is a positioning tether and at least one of the plurality of tethers is an anchoring tether.

17. The prosthetic heart valve of claim 15, further comprising wherein one of the plurality of tethers is attached to an epicardial tether securing device.

18. The prosthetic heart valve of claim 1, wherein the valve does not use an anchoring tether or a positioning tether at all, and instead is held in the mitral annulus by the wrapping forces of the native leaflets, and optionally one or more standard anchoring elements, including but not limited to barbs, pins, and/or hooks, or combinations thereof.

19. A method of treating mitral regurgitation in a patient, which comprises the step of surgically deploying the prosthetic heart valve of claim 1 into the mitral annulus of the patient.

20. The method of claim 19, wherein the prosthetic heart valve is deployed by directly accessing the heart through the intercostal space, using an apical approach to enter the left ventricle, and deploying the prosthetic heart valve into the mitral annulus using a catheter delivery system.

21-27. -27. (canceled)